Enhancement of polymorphonuclear leukocyte (PMN) function by OK-432

International Journal of Immunopharmacology - Tập 16 - Trang 7-17 - 1994
E. Ueta1, M. Umazume1, T. Yamamoto1, T. Osaki1
1Department of Oral Surgery, Kochi Medical School, Kohasu, Oko-cho, Nankoku-city, Kochi 783, Japan

Tài liệu tham khảo

Allavena, 1989, Killing of tumor cells with pleiotropic drug resistance by OK-432 activated effector cells, Immunopharm. Immunotox., 11, 257, 10.3109/08923978909005369 Antman, 1989, Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression, New Engl. J. Med., 319, 593, 10.1056/NEJM198809083191001 Berton, 1986, Gamma interferon is able to enhance the oxidative metabolism of human neutrophils, Biochem. biophys. Res. Commun., 138, 1276, 10.1016/S0006-291X(86)80421-1 Bonavida, 1989, Activation of human peripheral blood derived monocytes by OK-432 (streptococcus pyogenes): augmented cytoxicity and secretion of TNF and synergy with rIFN-γ, Cell. Immun., 123, 373, 10.1016/0008-8749(89)90297-9 Borish, 1989, Activation of neutrophils by recombinant interleukin-6, Cell. Immun., 121, 280, 10.1016/0008-8749(89)90026-9 Cantorna, 1991, Role of CD4+ lymphocytes in resistance to mucosal candidiasis, Infect. Immun., 59, 2447, 10.1128/IAI.59.7.2447-2455.1991 Christmas, 1986, Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK-432, Int. J. Immunopharmac., 8, 83, 10.1016/0192-0561(86)90076-7 Danis, 1990, Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN)-gamma, tumor necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha, Clin. exp. Immun., 80, 435, 10.1111/j.1365-2249.1990.tb03306.x Djeu, 1987, Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor, J. Immun., 139, 2761 Ferrante, 1989, Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release, Infect. Immun., 57, 2115, 10.1128/IAI.57.7.2115-2122.1989 Figari, 1987, Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factor-α and β: comparison to recombinant interferon-γ and interleukin-1, Blood, 70, 979, 10.1182/blood.V70.4.979.979 Fukase, 1988, Priming activity for chemiluminescence of PMN in the culture supernatant of streptococcal preparation (OK-432)-stimulated spleen cells, Microbiol. Immun., 32, 621, 10.1111/j.1348-0421.1988.tb01423.x Ichimura, 1985, Augmentation of interleukin-1 and interleukin-2 production by OK-432, Int. J. Immunopharmac., 7, 263, 10.1016/0192-0561(85)90035-9 Ichinose, 1986, Influence of chemotherapy on superoxide anion-generating activity of polymorphonuclear leukocytes in patients with lung cancer, Cancer, 58, 1663, 10.1002/1097-0142(19861015)58:8<1663::AID-CNCR2820580815>3.0.CO;2-I Kullberg, 1990, Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1, Infect. Immun., 58, 3319, 10.1128/IAI.58.10.3319-3324.1990 Martin, 1991, Quantitative analysis of opsonophagocytosis and killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry, J. clin. Microbiol., 29, 2013, 10.1128/JCM.29.9.2013-2023.1991 Matamoros, 1983, Effect of cancer chemotherapeutic agents on the chemiluminescence of human granulocytes, Pharmacology, 27, 29, 10.1159/000137827 Matsumoto, 1982, Increased sensitivity of the fluorometric method of Snyder and Hendley for oxidase assays, Biochem. Pharmac., 31, 2207, 10.1016/0006-2952(82)90520-2 Morikage, 1990, Prevention of fatal infections by recombinant human interleukin-1 alpha in normal and anti-cancer drug-treated mice, Cancer Res., 50, 2099 Noda, 1986, Interferon-gamma induction in human peripheral blood mononuclear cells by OK-432, a killed preparation of streptococcus pyogenes, Microbiol. Immun., 30, 81, 10.1111/j.1348-0421.1986.tb00923.x Oppenheim, 1990, Regulation of the production and receptors for interleukin-1, and tumor necrosis factor, Prog. clin. Biol. Res., 349, 183 Rieckmann, 1991, IL-6 and tumor necrosis factor-α: autocrine and paracrine cytokines involved in B-cell function, J. Immun., 146, 3462 Sasada, 1987, Candidacidal activity of monocyte-derived human macrophages: relationship between Candida killing and oxygen radical generation by human macrophages, J. Leukocyte Biol., 41, 289, 10.1002/jlb.41.4.289 Sekimoto, 1988, Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma, J. clin. Lab. Immun., 27, 115 Stellman, 1986, Cancer chemotherapeutic agents as occupational hazards: a literature review, Cancer Invest., 4, 127, 10.3109/07357908609038255 Tauber, 1987, Protein kinase C and the activation of human neutrophil NADPH-oxidase, Blood, 169, 711, 10.1182/blood.V69.3.711.711 Thompson, 1992, Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions, Clin. exp. Immun., 87, 316, 10.1111/j.1365-2249.1992.tb02994.x Torisu, 1983, New approach to management of malignant ascites with a streptococcal preparation OK-432. I. Improvement of host immunity and prolongation of survival, Surgery, 93, 357 Wray, 1991, Polymorphonuclear neutrophil function in recurrent aphthous stomatitis, J. Oral Pathol. Med., 20, 392, 10.1111/j.1600-0714.1991.tb00951.x Yamaue, 1987, Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK-432, Cancer Immun. Immunother., 25, 169, 10.1007/BF00199143 Yoshikawa, 1989, Augmentative effect of OK-432 and/or Nocardia rubra cell wall skeleton on superoxide generation from polymorphonuclear leukocytes, Jap. J. Clin. Immun., 12, 608, 10.2177/jsci.12.608